Using our AI model trained on historical seasonal data, we generated a 12-month forecast for Apimeds Pharmaceuticals US Inc. The model predicts a median target price of Unlock Pro , ranging from Unlock Pro to Unlock Pro , indicating a Unlock Pro from the current price of Unlock Pro . This forecast is based on comprehensive analysis of seasonal patterns, market trends, and historical performance data to provide insights into the stock's potential trajectory over the next twelve months.